Intraday Price Movement and Volatility
On 24 Dec 2025, Nexus Surgical and Medicare experienced a notable intraday price range, touching a high of Rs.17.44, which represented an 11.79% increase from the previous close. However, the stock also recorded an intraday low of Rs.13.26, a 15% drop, ultimately closing at this new 52-week low. This wide price fluctuation resulted in an intraday volatility of 13.62%, calculated from the weighted average price, indicating heightened uncertainty among market participants.
The stock's decline followed a four-day period of consecutive gains, signalling a reversal in short-term momentum. Additionally, the day's performance underperformed its sector by 14.96%, underscoring the relative weakness of Nexus Surgical and Medicare compared to its NBFC peers.
Technical Indicators and Moving Averages
From a technical perspective, Nexus Surgical and Medicare is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a sustained downward trend over multiple time horizons. The stock's current price of Rs.13.26 is less than half of its 52-week high of Rs.29.28, highlighting the extent of the decline over the past year.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
See What's Driving the Rally →
Comparative Market Context
While Nexus Surgical and Medicare has seen its stock price fall by 47.73% over the last year, the Sensex index has recorded a positive change of 8.84% during the same period. The Sensex was trading at 85,408.70 on the day, down marginally by 0.14% after a flat opening. It remains close to its 52-week high of 86,159.02, just 0.88% away, and is positioned above its 50-day moving average, which itself is above the 200-day moving average, indicating a generally bullish market environment contrasting with the stock’s performance.
Financial Performance and Valuation Metrics
Nexus Surgical and Medicare’s financial data reveals a complex picture. The company’s operating profits have shown a compound annual growth rate (CAGR) of -2.97%, reflecting a contraction over the longer term. Despite this, profits have risen by 11% over the past year, suggesting some near-term improvement in earnings.
The company’s return on equity (ROE) stands at 37.4%, which is relatively high. However, this is accompanied by a price-to-book value ratio of 6.1, indicating a valuation that is considered expensive relative to book value. Notably, the stock is trading at a discount compared to the average historical valuations of its peers within the NBFC sector.
Long-Term and Recent Performance Trends
Over the last three years, Nexus Surgical and Medicare has underperformed the BSE500 index across multiple time frames, including the one-year and three-month periods. The stock’s return of -47.73% over the past year contrasts with the broader market’s positive trajectory, highlighting challenges in maintaining competitive performance.
Shareholding Pattern
The majority of the company’s shares are held by non-institutional investors, which may influence trading dynamics and liquidity. This ownership structure can sometimes lead to increased volatility, especially during periods of market uncertainty.
Considering Nexus Surgical and Medicare ? Wait! SwitchER has found potentially better options in Non Banking Financial Company (NBFC) and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Non Banking Financial Company (NBFC) + beyond scope
- - Top-rated alternatives ready
Sector and Industry Considerations
Nexus Surgical and Medicare operates within the Non Banking Financial Company (NBFC) sector, which has experienced varied performance across different players. The sector’s overall dynamics, including regulatory developments and credit environment, can impact individual stock performance. The stock’s recent underperformance relative to its sector peers suggests specific company-level factors are influencing its price movement.
Summary of Key Price and Performance Data
To summarise, the stock’s new 52-week low of Rs.13.26 represents a significant milestone in its price trajectory, down from a 52-week high of Rs.29.28. The day’s trading session was marked by high volatility and a reversal after a short rally. Nexus Surgical and Medicare’s valuation metrics and financial results reflect a mixed scenario, with some profit growth but longer-term contraction in operating profits and a valuation that remains elevated relative to book value.
These factors combined have contributed to the stock’s current position below all major moving averages and its underperformance relative to the broader market indices and sector peers.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →
